Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Fractal Analytics, Park Medi, two others slip up to 7% as lock-in for 3.6 crore shares expires today
Following the end of IPO lock-in periods on March 16, Fractal Analytics, Aye Finance, Park Medi World, and Nephrocare Health Services faced share price drops. This release of 3.6 crore shares marks the beginning of a potential $72 billion unlock for 88 companies through 2026.
Nuvama sees 37% upside in this healthcare stock. Should you buy?
Park Medi World is set to benefit from India's hospital bed shortage and growth in Tier II markets. Nuvama initiated coverage with a 'Buy' rating and a target price of ₹280, projecting a 37% upside. The company aims to expand bed capacity significantly by FY28.
Park Medi World stock price climbs to a new peak after this update
Park Medi World shares, which listed on the exchanges on December 17 last year, jumped as much as 3.5% to a new peak of ₹208.72 apiece. The IPO investors are meanwhile enjoying 30% returns on their investment as against the offer price of ₹162 apiece.
CIDCO plans 120-acre commercial hub in Navi Mumbai, floats tender for 20-year development
CIDCO has invited bids to develop a 120-acre International Corporate Park in Navi Mumbai's Kharghar, aiming to create a new business district akin to BKC. This initiative, under the state's Theme-Based policy, seeks a private developer via competitive bidding to foster a world-class corporate ecosystem and boost Navi Mumbai's economic growth.
Park Medi shares jump 8% to hit fresh record high on Rs 177-crore acquisition of VS Healthcare
Park Medi stock opened with a gain of 2% and has risen around 9% over the last two trading sessions.
Buy Park Medi World; target of Rs 320: Choice Institutional Equities
Choice Institutional Equities is bullish on Park Medi World has recommended buy rating on the stock with a target price of Rs 320 in its research report dated April 30, 2026.
Buy Park Medi World; target of Rs 350: Emkay Global Financial
Emkay Global Financial is bullish on Park Medi World has recommended buy rating on the stock with a target price of Rs 350 in its research report dated Jun 18, 2026.
Park Medi World shares climb to fresh high on expansion announcement
The company made its market debut in December 2025, listing at Rs 155.60 per share on the BSE.
Park Medi World shares rise 3% on as company announces Gurugram expansion, outlines Rs 500 crore growth plan
In an interaction with CNBC-TV18, Sudesh Sharma, Chief Financial Officer of Park Medi World, said the company is on track to significantly expand its network over the next two years